SILVERARC CAPITAL MANAGEMENT, LLC
CIK: 0001816307Latest portfolio: $720.0M · Q4 2025
Holdings
68
Total Value
$720.0M
New Positions
18
Closed Positions
30
Top Holdings
View All 68 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 422,193 | $56.9M | 7.91% | -117,511 | |
| 2 | COGTCOGENT BIOSCIENCES INC | 1,245,254 | $44.2M | 6.14% | +430K | |
| 3 | URGNUROGEN PHARMA LTD | 1,738,821 | $40.7M | 5.66% | +162K | |
| 4 | KALVKALVISTA PHARMACEUTICALS INC | 2,427,118 | $39.2M | 5.44% | +1.1M | |
| 5 | CELCCELCUITY INC | 375,132 | $37.4M | 5.20% | +286K | |
| 6 | NUVLNUVALENT INC | 311,430 | $31.3M | 4.35% | -60,870 | |
| 7 | DNTHDIANTHUS THERAPEUTICS INC | 750,136 | $30.9M | 4.29% | +75K | |
| 8 | KODKODIAK SCIENCES INC | 1,023,122 | $28.6M | 3.97% | +23K | |
| 9 | PRAXPRAXIS PRECISION MEDICINES I | 82,465 | $24.3M | 3.38% | +31K | |
| 10 | IMNMIMMUNOME INC | 1,126,210 | $24.2M | 3.36% | NEW | |
| 11 | GUTSFRACTYL HEALTH INC | 9,840,041 | $21.6M | 3.01% | -759,959 | |
| 12 | QUREUNIQURE NV | 720,800 | $17.2M | 2.40% | NEW | Call |
| 13 | GLUEMONTE ROSA THERAPEUTICS INC | 1,029,066 | $16.1M | 2.24% | +334K | |
| 14 | VCYTVERACYTE INC | 357,558 | $15.1M | 2.09% | +122K | |
| 15 | CGONCG ONCOLOGY INC | 361,158 | $15.0M | 2.08% | -277,188 | |
| 16 | RYTMRHYTHM PHARMACEUTICALS INC | 135,950 | $14.6M | 2.02% | -234,046 | |
| 17 | SNDXSYNDAX PHARMACEUTICALS INC | 642,899 | $13.5M | 1.88% | +179K | |
| 18 | BIIBBIOGEN INC | 75,412 | $13.3M | 1.84% | -5,007 | |
| 19 | IM8NINSMED INC | 71,256 | $12.4M | 1.72% | -135,392 | |
| 20 | CNTACENTESSA PHARMACEUTICALS PLC | 458,203 | $11.5M | 1.59% | +317K | |
| 21 | VRDNVIRIDIAN THERAPEUTICS INC | 348,569 | $10.8M | 1.51% | +89K | |
| 22 | ASNDASCENDIS PHARMA A/S | 49,228 | $10.5M | 1.46% | -4,326 | |
| 23 | PFEPFIZER INC | 419,134 | $10.4M | 1.45% | NEW | |
| 24 | BNTCBENITEC BIOPHARMA INC | 731,717 | $9.9M | 1.37% | +455K | |
| 25 | AVTXAVALO THERAPEUTICS INC | 524,436 | $9.5M | 1.32% | -196,486 |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
Healthcare0.0% ($5.693444231407235e+266T)
Unknown0.0% ($124.0B)
Technology0.0% ($2K)
Filing History
Fund Information
SILVERARC CAPITAL MANAGEMENT, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $720.0M across 68 holdings. The largest position is ABIVAX SA (ABVX), representing 7.9% of the portfolio. Compared to the previous quarter, the fund opened 21 new positions and closed 35 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.